International
Lilly Drug Slows Alzheimer’s By 60%
USA – Eli Lilly’s experimental drug Donanemab slowed the progression of Alzheimer’s by 60% for patients in the earliest stages of the brain-wasting disease.
-
National13 hours agoFormer Trainee Corrections Officer Pleads Guilty To Smuggling Drugs Into Prison
-
Court13 hours ago19-Year-Old Man Accused Of Double Shooting Behind Bars
-
Entertainment3 days agoMannie Fresh Set to Make Debut at Jon Batiste’s Jazz Club
-
National3 days agoChristian Council Holds Memorial for Fatal Independence Plane Crash Victims
-
Sports3 days agoBernie Butler Swim Meet Held in Grand Bahama
-
National13 hours ago11 Families Receive Keys to New Homes Through Rent-to-own Program
-
National3 days agoLocal Multimedia CEO Represents Country in Belize
-
National3 days agoDon’t Speculate, Let The Police Investigate Minister Says



